XTRX Stock Overview
Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Adastra Holdings Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.45 |
| 52 Week High | CA$2.90 |
| 52 Week Low | CA$0.20 |
| Beta | -0.36 |
| 11 Month Change | -16.67% |
| 3 Month Change | -50.00% |
| 1 Year Change | -81.63% |
| 33 Year Change | -95.36% |
| 5 Year Change | n/a |
| Change since IPO | -96.88% |
Recent News & Updates
Market Cool On Adastra Holdings Ltd.'s (CSE:XTRX) Revenues Pushing Shares 26% Lower
Oct 23
Market Cool On Adastra Holdings Ltd.'s (CSE:XTRX) Revenues Pushing Shares 26% Lower
Sep 08Is Adastra Holdings (CSE:XTRX) A Risky Investment?
Sep 04Recent updates
Market Cool On Adastra Holdings Ltd.'s (CSE:XTRX) Revenues Pushing Shares 26% Lower
Oct 23Market Cool On Adastra Holdings Ltd.'s (CSE:XTRX) Revenues Pushing Shares 26% Lower
Sep 08Is Adastra Holdings (CSE:XTRX) A Risky Investment?
Sep 04Adastra Holdings Ltd. (CSE:XTRX) Might Not Be As Mispriced As It Looks After Plunging 41%
Jul 11Adastra Holdings Ltd. (CSE:XTRX) Might Not Be As Mispriced As It Looks After Plunging 27%
May 08Adastra Holdings Ltd.'s (CSE:XTRX) Shares Leap 26% Yet They're Still Not Telling The Full Story
Mar 08Adastra Holdings Ltd.'s (CSE:XTRX) Shares Not Telling The Full Story
Jan 23Here's Why Adastra Holdings (CSE:XTRX) Can Afford Some Debt
Sep 28Subdued Growth No Barrier To Adastra Holdings Ltd.'s (CSE:XTRX) Price
Aug 03Does Adastra Holdings (CSE:XTRX) Have A Healthy Balance Sheet?
Jan 13We Think Adastra Holdings (CSE:XTRX) Has A Fair Chunk Of Debt
Sep 28Does Adastra Holdings (CSE:XTRX) Have A Healthy Balance Sheet?
Mar 23Here's Why Adastra Holdings (CSE:XTRX) Can Afford Some Debt
Dec 07Here's Why Phyto Extractions (CSE:XTRX) Can Afford Some Debt
Aug 18Auditors Have Doubts About Phyto Extractions (CSE:XTRX)
May 04Adastra Labs Holdings (CSE:XTRX) Is Making Moderate Use Of Debt
Dec 10Shareholder Returns
| XTRX | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -33.8% | 0.03% | 1.3% |
| 1Y | -81.6% | -20.8% | 23.7% |
Return vs Industry: XTRX underperformed the Canadian Pharmaceuticals industry which returned -21.1% over the past year.
Return vs Market: XTRX underperformed the Canadian Market which returned 23% over the past year.
Price Volatility
| XTRX volatility | |
|---|---|
| XTRX Average Weekly Movement | 54.3% |
| Pharmaceuticals Industry Average Movement | 11.6% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CA Market | 17.5% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: XTRX's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: XTRX's weekly volatility has increased from 32% to 54% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | adastraholdings.ca |
Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada. The company offers vape pens, wax, resin, infused pre-rolls, diamonds, and shatters under the Endgame brand name. It also provides consulting, white label manufacturing, and tolling services; and licenses its intellectual property for the sale of consumer-packaged goods.
Adastra Holdings Ltd. Fundamentals Summary
| XTRX fundamental statistics | |
|---|---|
| Market cap | CA$2.52m |
| Earnings (TTM) | -CA$3.36m |
| Revenue (TTM) | CA$22.75m |
0.1x
P/S Ratio-0.7x
P/E RatioIs XTRX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| XTRX income statement (TTM) | |
|---|---|
| Revenue | CA$22.75m |
| Cost of Revenue | CA$14.56m |
| Gross Profit | CA$8.19m |
| Other Expenses | CA$11.55m |
| Earnings | -CA$3.36m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.60 |
| Gross Margin | 36.00% |
| Net Profit Margin | -14.78% |
| Debt/Equity Ratio | 26.4% |
How did XTRX perform over the long term?
See historical performance and comparison